Source comparison
BPC-157 Timeline: Route & Injury Type Comparison
The timeline for how long BPC-157 takes to work varies significantly based on administration route, injury type, dose frequency, and whether the peptide is used as monotherapy or in combination with other regenerative compounds. This table summarizes evidence-
This comparison does not assign a generated winner or score.
- The timeline for how long BPC-157 takes to work varies significantly based on administration route, injury type, dose frequency, and whether the peptide is used as monotherapy or in combination with other regenerative compounds. This table summarizes evidence-based timelines from published preclinical models.
- Acute muscle strain/tear
- Local subcutaneous injection near injury
- 48–72 hours (reduced swelling, improved ROM)
- 3–4 weeks (collagen remodeling complete)
- 200–500 mcg daily, 4–6 weeks
- Early anti-inflammatory effect via cytokine modulation; angiogenesis begins day 3–5
- Tendon injury (Achilles, patellar)
- Local injection or systemic subcutaneous
- 5–7 days (functional weight-bearing improvement)
- 4–6 weeks (tensile strength 85–90% recovery)
- 250–500 mcg daily, 6 weeks minimum
- Fibroblast proliferation and Type I collagen deposition are rate-limiting; mechanical load influences timeline
- Gastric ulcer/mucosal damage
- Oral (capsule) or intragastric injection
- 5–10 days (reduced ulcer area, mucosal thickness increase)
- 2–3 weeks (complete epithelial closure)
- 10 mcg/kg daily oral, 14–21 days
- Direct cytoprotective effect on gastric epithelium; does not require systemic circulation for efficacy
- Bone fracture (non-union research models)
- Systemic subcutaneous injection
- 10–14 days (early callus formation visible on imaging)
- 6–8 weeks (radiographic union and load-bearing capacity)
- 10 mcg/kg daily, 8 weeks
- Angiogenesis in fracture gap is critical; BPC-157 enhances VEGF-driven vascularization of callus tissue
- Ligament sprain (MCL, ACL models)
- Local injection at ligament insertion
- 7–10 days (reduced joint laxity, improved proprioception)
- 5–6 weeks (restoration of ligament continuity and strength)
- 200–400 mcg daily, 6 weeks
- Ligament healing is slower than muscle due to lower baseline vascularization; BPC-157 addresses this via angiogenesis
- Peripheral nerve injury (crush/transection models)
- Systemic injection or perineural injection
- 14–21 days (early axonal sprouting, reduced neuropathic pain markers)
- 8–12 weeks (functional motor recovery, nerve conduction velocity improvement)
- 10 mcg/kg daily, 12 weeks
- Nerve regeneration is the slowest tissue repair process; BPC-157 enhances Schwann cell activity and axon guidance